Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 2

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 267Thoracic 255Genitourinary 191Gastrointestinal 156Head & Neck 121Gynecologic 47Sarcoma 25Tumor-Agnostic 12Other solid neoplasm 10Dermatologic 5Endocrine 3CNS 3Other hematologic neoplasm 1Other 1Lymphoid 1Classical hematology 1

Conditions

Thyroid Carcinoma, Anaplastic 1Neoplasms 1Carcinoma, Neuroendocrine 1Adrenocortical Carcinoma 1

Interventions

Everolimus 27pembrolizumab 25Temozolomide 24lutetium Lu 177 dotatate 22Nivolumab 18Magnetic Resonance Spectroscopy 18lenvatinib 17cabozantinib 17Cisplatin 16Sunitinib 15Capecitabine 14Bevacizumab 14Specimen Handling 12Sorafenib 12trametinib 10Ipilimumab 10Etoposide 10pasireotide 9dabrafenib 9Paclitaxel 9Carboplatin 8pazopanib 7lanreotide 7Octreotide 7Fluorodeoxyglucose F18 7anlotinib 6Irinotecan 6Injections 6Doxorubicin 6surufatinib 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Docetaxel × Endocrine × Clear all
NCT03837977 2024-12-30

NET02

The Christie NHS Foundation Trust

Phase 2 Completed
58 enrolled
Endocrine

Neoplasms, Carcinoma, Neuroendocrine

NCT03211117 2020-03-25

Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer

Mayo Clinic

Phase 2 Completed
3 enrolled 7 charts
EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic

NCT00324012 2012-02-22

Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma

Rigshospitalet, Denmark

Phase 2 Completed
19 enrolled
Endocrine

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡